Project Details
Project Description
| Status | Active |
|---|---|
| Effective start/end date | 13/01/22 → 31/12/27 |
Keywords
- Malignant Haematology
- Multiple myeloma
- Clinical trial
Clinical Trial Phase
- Phase I
- Phase II
An Open-Label, Multicenter, Phase 1/2 Trial of GEN3014 (HexaBody®-CD38) in Relapsed or Refractory Multiple Myeloma and Other Hematologic Malignancies.
- Spencer, Andrew (Primary Chief Investigator (PCI))
- Kennedy, Nola (Project Manager)
- Ho, Phoebe Joy (Chief Investigator (CI))
- Cochrane, Tara (Chief Investigator (CI))
- Cooke, Rachel Elizabeth (Chief Investigator (CI))
Project: Research